Roman Butler Fullerton & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,541
| Closed | -$1.22M | – | 199 |
|
|
2023
Q1 | $1.22M | Buy |
1,541
+117
| +8% | +$92.4K | 0.61% | 46 |
|
|
2022
Q4 | $1.04M | Sell |
1,424
-402
| -22% | -$293K | 0.54% | 58 |
|
|
2022
Q3 | $1.35M | Buy |
+1,826
| New | +$1.35M | 0.86% | 28 |
|
|
2020
Q4 | – | Sell |
-1,401
| Closed | -$784K | – | 177 |
|
|
2020
Q3 | $784K | Hold |
1,401
| – | – | 0.51% | 63 |
|
|
2020
Q2 | $874K | Buy |
1,401
+318
| +29% | +$198K | 0.62% | 57 |
|
|
2020
Q1 | $529K | Buy |
+1,083
| New | +$529K | 0.47% | 69 |
|
|
2019
Q1 | – | Sell |
-1,095
| Closed | -$447K | – | 182 |
|
|
2018
Q4 | $447K | Buy |
+1,095
| New | +$447K | 0.38% | 97 |
|